1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Cancer Drug News 16 MARCH 2015

Cancer Drug News 16 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Targeted Oncology Medicine Continues To Drive Spending
Industry Brief - Eisai's Halaven To Remain On NCDF Pending Reconsideration
Industry Brief - Puma Initiates PB272 Phase II Trial In Early-Stage HER2-Positive BC
Industry Brief - AB Science Plans Next Step With Masitinib Following Positive PII Data In TNBC
Industry Brief - Eisai/Epizyme Update Agreement For EZH2 Epigenetic Enzyme
Industry Trend Analysis - Kura Will Succeed With Tipifarnib Where J&J Failed
Industry Trend Analysis - Heat Biologics' Candidate To Meet Early Approval To Fill NMIBC Unmet Medical Need
Industry Brief - ISA Pharmaceuticals/SNBL Sign R&D Agreement For Nasal CC Immunotherapeutic
Industry Brief - GOG Begins Enrolment In Stage II Of ADXS-HPV Phase II CC Study
Industry Brief - FDA Approves Unituxin For Paediatric High-Risk Neuroblastoma
Industry Brief - Pembrolizumab Accepted Under EAMS In UK For Advanced Melanoma
Industry Trend Analysis - Universal Cancer Diagnostics Edging Closer To Market
Industry Brief - Genmab Not To Exercise Co-Development Right For HuMax-TAC-ADC
Industry Brief - Kinex To Lead Orascovery Programme Development In India
Industry Brief - Actavis See Success In German Pemetrexed Patent Challenge
Industry Brief - NHS Delists Sanofi's Jevtana/Zaltrap From CDF
Industry Brief - Amgen's Neulasta Delivery Kit Available In US
Industry Brief - DARA Acquires US Rights To Oravig From Onxeo
Industry Brief - OSE Pharma Launches IPO On Euronext Paris
Industry Trend Analysis - J&J Poised For Pharmaceutical Acquisition

Table Of Contents

Cancer Drug News 16 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.